Expression of type 5 somatostatin receptor in TSH-secreting pituitary adenomas: a possible marker for predicting long-term response to octreotide therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/17159301

Download in:

View as

General Info

PMID
17159301